A Money-Back Guarantee on a Cancer Drug

Roche Holding is trying a radical new protocol to reverse a slump in sales of blockbuster cancer therapy Avastin. The Swiss drugmaker is offering hospitals and insurers in Germany a money-back guarantee on the drug, whose price is between $4,110 and $8,220 per month, depending on the cancer targeted.
Businessweek